Cargando…

Medical Therapy of Fibrostenotic Crohn's Disease

INTRODUCTION: The present review serves to provide a concise overview of the current knowledge on therapeutic strategies with regard to fibrostenotic lesions in Crohn's disease. METHODS: A literature search was performed focusing on the last 5 years, and current concepts of pathophysiology, epi...

Descripción completa

Detalles Bibliográficos
Autor principal:	Siegmund, Britta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620591/ https://www.ncbi.nlm.nih.gov/pubmed/26557834 http://dx.doi.org/10.1159/000435868

Ejemplares similares

Fibrostenotic strictures in Crohn’s disease
por: Yoo, Jun Hwan, et al.
Publicado: (2020)

Obliterative Muscularization of the Small Bowel Submucosa in Fibrostenotic Crohn's Disease
por: McNeill, Matthew B., et al.
Publicado: (2020)

Nutritional interventions in adult fibrostenotic Crohn’s disease: A systematic review
por: Cooper, Jared L., et al.
Publicado: (2023)

Magnetic Resonance Enterography and Histology in Patients With Fibrostenotic Crohn's Disease: A Multicenter Study
por: Coimbra, Alexandre, et al.
Publicado: (2022)

A107 VISCERAL ADIPOSE TISSUE VOLUME DIFFERENTIATES BETWEEN FIBROSTENOTIC AND INFLAMMATORY CROHN’S DISEASE
por: Rosentreter, R, et al.
Publicado: (2023)

A192 EFFICACY OF USTEKINUMAB IN SMALL BOWEL STRICTURES OF FIBROSTENOTIC CROHN'S DISEASE AS ASSESSED BY INTESTINAL ULTRASOUND
por: St-Pierre, J, et al.
Publicado: (2023)

Worse outcomes and higher costs of care in fibrostenotic Crohn’s disease: a real-world propensity-matched analysis in the USA
por: Dehghan, Melody, et al.
Publicado: (2021)

A rare case of fibrostenotic endobronchial tuberculosis of trachea
por: Cary, Cassiopia, et al.
Publicado: (2015)

Refractory Pediatric Fibrostenotic Eosinophilic Esophagitis Treated With Dupilumab
por: Gangadharan Nambiar, Gopinathan, et al.
Publicado: (2022)

Progression from an Inflammatory to a Fibrostenotic Phenotype in Eosinophilic Esophagitis
por: Koutlas, Nathaniel T., et al.
Publicado: (2017)

Worsened Fibrostenotic Outcomes in Eosinophilic Esophagitis Patients Due to COVID-19-Related Endoscopy Cancellations
por: Ocampo, Adolfo A., et al.
Publicado: (2022)

Intestinal Microbiota and the Innate Immune System – A Crosstalk in Crohn’s Disease Pathogenesis
por: Haag, Lea-Maxie, et al.
Publicado: (2015)

Early Comparison of Inflammatory vs. Fibrostenotic Phenotype in Eosinophilic Esophagitis in a Multicenter Longitudinal Study
por: Singla, Manish B, et al.
Publicado: (2015)

Medical therapies for postoperative Crohn’s disease
por: Shah, Ravi S., et al.
Publicado: (2021)

Medical Therapy of Perianal Crohn's Disease
por: Klag, Thomas, et al.
Publicado: (2015)

Ileal and colonic Crohn's disease: Does location makes a difference in therapy efficacy?
por: Atreya, Raja, et al.
Publicado: (2022)

Approach to medical therapy in perianal Crohn’s disease
por: Vasudevan, Abhinav, et al.
Publicado: (2021)

Pregnancy and Crohn’s disease: concerns and assurance of medical therapy
por: Chowdhury, Reezwana, et al.
Publicado: (2022)

Corrigendum to ‘A rare case of fibrostenotic endobronchial tuberculosis of trachea’ [Ann. Med. Surg. 4 (2015) 479–482]
por: Cary, Cassiopia, et al.
Publicado: (2016)

Inflammatory Bowel Diseases: Current Medical and Surgical Therapy
por: Lamprecht, Georg, et al.
Publicado: (2015)

Practical Medical Management of Crohn's Disease
por: Baran, Bulent, et al.
Publicado: (2013)

Anti-TNF Therapy in Crohn’s Disease
por: Adegbola, Samuel O., et al.
Publicado: (2018)

The Multifaceted Role of the Inflammasome in Inflammatory Bowel Diseases
por: Lissner, Donata, et al.
Publicado: (2011)

Nutritional Therapy Strategies in Pediatric Crohn’s Disease
por: Verburgt, Charlotte M., et al.
Publicado: (2021)

Medical and surgical management of perianal Crohn’s disease
por: Adegbola, Samuel O., et al.
Publicado: (2018)

Enteral Nutrition in Crohn's Disease: An Underused Therapy
por: Kansal, S., et al.
Publicado: (2013)

Feasibility of in vivo magnetic resonance elastography of mesenteric adipose tissue in Crohn’s disease
por: Jensen, Laura J., et al.
Publicado: (2023)

Economic implications of biological therapy for Crohn's disease
por: Petryszyn, Paweł W., et al.
Publicado: (2015)

Infliximab therapy in pediatric Crohn’s disease: a review
por: Parashette, Kalyan Ray, et al.
Publicado: (2010)

Medical Management of Crohn's Disease
por: Gade, Ajay K, et al.
Publicado: (2020)

Janus Kinase inhibitors in the New Treatment Paradigms of Inflammatory Bowel Disease
por: Siegmund, Britta
Publicado: (2020)

CROHN'S DISEASE
Publicado: (1972)

Crohn's Disease
Publicado: (1973)

Postoperative diarrhea in Crohn’s disease: Pathogenesis, diagnosis, and therapy
por: Wu, En-Hao, et al.
Publicado: (2023)

An evidence-based review of natalizumab therapy in the management of Crohn’s disease
por: Edula, Raja GR, et al.
Publicado: (2009)

Biologic therapies for Crohn’s disease: optimising the old and maximising the new
por: Samaan, Mark, et al.
Publicado: (2019)

Anti-Adhesion Therapies in Inflammatory Bowel Disease—Molecular and Clinical Aspects
por: Zundler, Sebastian, et al.
Publicado: (2017)

Celiac Disease: Role of the Epithelial Barrier
por: Schumann, Michael, et al.
Publicado: (2017)

Adalimumab in Crohn’s disease
por: Van Assche, Gert, et al.
Publicado: (2007)

Crohn’s disease in women
por: Plavšić, Ivana, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_07kihdr8juccugcmv8dkqsdqc0